8
Views
6
CrossRef citations to date
0
Altmetric
Original Article

Does Combined Therapy of Ca-channel Blocker and Angiotensin Converting Enzyme Inhibitor Exceed Monotherapy in Renal Protection Against Hypertensive Injury in Rats?

, , , , , & show all
Pages 243-256 | Received 05 Apr 1995, Accepted 05 Oct 1995, Published online: 03 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Yoshihiko Kanno, Hirokazu Okada, Tsuneo Takenaka, Takao Saruta & Hiromichi Suzuki. (2000) INFLUENCE OF THE TIMING OF INITIATING ANTIHYPERTENSIVE THERAPY IN HYPERTENSIVE RATS WITH RENAL FAILURE. Clinical and Experimental Hypertension 22:5, pages 521-529.
Read now

Articles from other publishers (5)

Dominique M. Bovée, Estrellita Uijl, David Severs, Eloisa Rubio-Beltrán, Richard van Veghel, Antoinette Maassen van den Brink, Jaap A. Joles, Robert Zietse, Catherina A. Cuevas, A. H. Jan Danser & Ewout J. Hoorn. (2021) Dietary salt modifies the blood pressure response to renin-angiotensin inhibition in experimental chronic kidney disease. American Journal of Physiology-Renal Physiology 320:4, pages F654-F668.
Crossref
J.M Teófilo, L.G Brentegani & T.L Lamano Carvalho. (2001) A histometric study in rats of the effect of the calcium antagonist amlodipine on bone healing after tooth extraction. Archives of Oral Biology 46:4, pages 375-379.
Crossref
T.L. Lamano-Carvalho, S.A. Almeida, J.M. Teófilo, J.A. Anselmo Franci & L.G. Brentegani. (2000) Antireproductive effect of the calcium channel blocker amlodipine in male rats. Experimental and Toxicologic Pathology 52:4, pages 353-356.
Crossref
K. Witte, A. Schnecko, T. Schmidt, C. Voll, B. Kränzlin & B. Lemmer. (1999) Cardiovascular risk, renal hypertensive damage, and effects of. General Pharmacology: The Vascular System 33:5, pages 423-430.
Crossref
Addison A. Taylor & Sarat Sunthornyothin. (1999) The case for combining angiotensinconverting enzyme inhibitors and calcium-channel blockers. Current Hypertension Reports 1:5, pages 446-453.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.